News About: Pharm. Industry


KRPIA appoints new chairman

The Korea Research-based Pharmaceutical Industry Association appointed on March 26 M. Richter, president of Boehringer Ingelheim Korea, the 6th chairman who will succeed an incumbent chairman Jan Peterse of Pharmacia ...

KPMA to enforce fair competition code for pharmaceutical firms

The Korea Pharmaceutical Manufacturers Association held an explanatory session towards the revised fair trade code on March 25, noting that if those firms, which were subject to the first collective order on the groun...

Local companies blocking Norvasc monopolistic sales.

Pfizer Korea has monopolized Norvasc (amlodipine besylate), an antihypertensive drug on the market with annual sales of about 120 billion won last year, which seems to be curbed by local competitors, Hanmi, CJ and CKD...

MSD Korea to collaborate with Zuellig Pharma Korea

MSD Korea said it would enter into a drug distribution contract with Zuellig Pharma Korea from this April 1 in a bid to operate more efficient distribution system and cope with sufficient human resources and broad ran...

Pfizer Korea decides to lower insurance price of Norvasc by 1 won

Pfizer Korea said the government should cut down the reimbursement price of Norvasc (amlopidpine), a long-acting calcium channel blocker, by 1 won from this April. The company said, "The government has informed us...

Chosun Pharm concentrates its efforts on streamlining its organizations as herbal maker

Chosun Pharm cerebrated its 78-year foundation day on March 14, renewing its determination as re-born herbal maker. In his congratulatory speech, Park Chong-whan, a committee chief for management normalization sai...

KPMA member companies to keep compliance with fair trade provisions.

The Korea pharmaceutical manufacturers association (KPMA) asked all member companies strictly to comply with the fair trade regulations in order to keep their management transparency and fair trade climates in the mar...

Inevitable price reduction of simvastatin preparations probable

Influenced by the voluntary reimbursement price cut of MSD Korea's Zocor, which has dominated the domestic anti-hyperlipemic market, the overall price of its generic versions seems likely to be lowered in rows. MSD...

Pharmaceutical technologies fast transferring to China

The Korea New Drug R&D Association (KNDRDA) and the Chinese National Health Science and Technology Industrial Base (CNHSTIB) have made a visible treaty framework for the pharmaceutical technology transfer under the ti...

Drug industry: Information control system requires urgent improvement.

The information control system in the domestic drug industry stood at a pretty much infant level, requiring an urgent improvement by extending the knowledge management system (KMS) to the industry as early as possible...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.